Patents Assigned to BIOMUNEX PHARMACEUTICALS
  • Polypeptide linker for preparing multispecific antibodies
    Patent number: 11958913
    Abstract: The present invention relates to a mutant polypeptide linker for preparing multispecific antibodies, multispecific antibodies, and methods for producing multispecific antibodies.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: April 16, 2024
    Assignee: BIOMUNEX PHARMACEUTICALS
    Inventors: Eugene Zhukovsky, Olivier Leger
  • Stable multispecific antibodies
    Patent number: 11560437
    Abstract: The invention relates to multispecific antibody constructs comprising Fab fragments having a particular set of mutations at the interface of the CH1 and CL domains, the mutations preventing heavy chain/light chain mispairing.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: January 24, 2023
    Assignee: BIOMUNEX PHARMACEUTICALS
    Inventors: Eugene Zhukovsky, Olivier Leger, Richard J. Morse
  • Binding molecules to CD38 and PD-L1
    Patent number: 11505616
    Abstract: The present invention relates to a bispecific molecule comprising at least one anti-CD38 domain and at leak one anti-PD-L1 domain, which are capable of simultaneous binding to CD38 and PD-L1 antigens, respectively.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: November 22, 2022
    Assignee: BIOMUNEX PHARMACEUTICALS
    Inventors: Eugene Zhukovsky, Olivier Leger, Richard J. Morse